3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Nausea

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with Nausea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrams, A; Biederman, J; Bostic, J; Fine, C; Monuteaux, MC; Polisner, D; Prince, J; Rater, M; Soriano, J; Spencer, TJ; Wilens, TE	1

Trials

1 trial(s) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Nausea

Article	Year
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. The American journal of psychiatry, 1999, Volume: 156, Issue:12 Topics: Administration, Cutaneous; Adult; Age Factors; Anti-Anxiety Agents; Attention Deficit Disorder with Hyperactivity; Cholinergic Agonists; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Isoxazoles; Male; Nausea; Pilot Projects; Pyrrolidines; Treatment Outcome	1999

Article

Year

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.

The American journal of psychiatry, 1999, Volume: 156, Issue:12

Topics: Administration, Cutaneous; Adult; Age Factors; Anti-Anxiety Agents; Attention Deficit Disorder with Hyperactivity; Cholinergic Agonists; Cross-Over Studies; Dizziness; Double-Blind Method; Female; Humans; Isoxazoles; Male; Nausea; Pilot Projects; Pyrrolidines; Treatment Outcome

1999